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We have previously observed that glucose deprivation
activates the ASK1-MEK-MAPK signal transduction
pathway. In the present study, we reveal that two scaf-
folding proteins, JIP1 and JIP3, have a cross-talk that
leads to the regulation of the ASK1-SEK1-JNK signal
during glucose deprivation. Glucose deprivation rapidly
increases the interaction between ASK1 and JIP3, and
the consequently activated ASK1 phosphorylates SEK1
on the Thr-261 residue. The activated SEK1 dissociates
from JIP3 and phosphorylates JNK2 on the Tyr-185 res-
idue. Phosphorylated JNK2 binds to JIP1, and the phos-
phorylation of the Thr-183 residue of JNK2 occurs. JNK2
phosphorylates JIP1 on the Thr-103 residue and leads to
dissociation of Akt1 from JIP1. Dissociated Akt1 binds
to SEK1 and ASK1 and inhibits their enzyme activity by
phosphorylating SEK1 on the Ser-80 residue and ASK1
on the Ser-83 residue. Taken together, our data demon-
strate that cross-talk between JIP3 and JIP1 is mediated
through SEK1-JNK2 and Akt1.
Cellular responses to external signals should accurately pro-
ceed without errors. Mitogen-activated protein kinases
(MAPKs)1 are components of pathways that relay signals me-
diating proliferation, survival, death, or cell cycle arrest to
particular cell compartments in response to a diverse array of
extracellular stimuli (1). Their ubiquity and versatility raise
the issue of how they achieve specific coupling of signal to
cellular response (2). Most prominent among the known signal
transduction pathways that control these events are the MAPK
cascades, whose components are evolutionarily highly con-
served in structure and organization, each cascade consisting
of a module of three cytoplasmic kinases: a MAPK kinase
kinase, a MAPK kinase, and the MAPK itself (3). The control of
diverse cellular processes in response to a plethora of extracel-
lular stimuli by a few MAPKs lies in the fact that considerable
specificity is built into MAPK activation and function (4). There
are two possible mechanisms that can operate in the cell. First,
the protein kinase forming the MAPK signaling modules may
interact via a series of sequential binary interactions to create
a protein kinase cascade, or scaffold proteins may mediate
signaling cascades by organizing the components of MAPK
signaling into modules (5). Scaffold proteins have been pro-
posed to serve as organizing centers for signal transduction,
and one function of scaffold proteins might be to reduce the
extent of cross-talk between different pathways sharing molec-
ular components (6).
We have previously observed that glucose deprivation acti-
vates the ASK1-MEK-MAPK signal transduction pathway. In
this study, we hypothesized that the ASK1-MEK-MAPK signal
transduction can be modulated through cross-talk between two
scaffold proteins during prolonged glucose deprivation, as rep-
resented schematically in Fig. 12. The first scaffold protein,
JIP3 (JNK-interacting protein 3, also named JSAP1 (JNK/
SAPK-associated protein 1)), a c-Jun N-terminal kinase (JNK)-
binding protein (7), can be phosphorylated by ASK1, and its
phosphorylation facilitates the recruitment of stress-activated
protein kinase/extracellular-signal regulated kinase (SEK1),
MKK7, and JNK into the JIP3-ASK1 signaling complex (8).
The binding between JIP3 and JNKs (including JNK1, -2, and
-3) is specific, whereas there is either no binding or very low
binding of ERK2 and p38 to JIP3 (7). The second scaffold
protein, JIP1, is a scaffold protein that integrates both positive
and negative regulators of JNK. JIP1 assembles JNK, MKK7,
and mixed lineage protein kinase proteins on different regions
of JIP1 and facilitates the JNK signaling pathway (9, 10).
Recent studies have revealed that recruitment of JNK to JIP1
and phosphorylation of JIP1 by JNK are prerequisites for ac-
tivation of the JNK module (11). Moreover, JNK activity can be
antagonized by Akt kinase activity in numerous cellular sys-
tems (12–15). In the present study, we observed that JNK
activation was regulated by cross-talk between JIP3-associated
proteins and JIP1-associated proteins during prolonged glucose
deprivation. JIP3-mediated activation of SEK1 and JIP1-me-
diated restoration of Akt1 activity play an important role in the
regulation of the ASK1-MEK-MAPK signal transduction path-
way during prolonged glucose deprivation.
MATERIALS AND METHODS
Cell Culture—Human prostate adenocarcinoma DU-145 cells were
cultured in Dulbecco’s modified Eagle’s medium with 10% fetal bovine
serum (HyClone, Logan, UT) and 26 mM sodium bicarbonate for mono-
layer cell culture. The cells were maintained in a humidified atmo-
sphere containing 5% CO2 and air at 37 °C.
Reagents and Antibodies—Polyclonal anti-SEK1, anti-phospho-Thr-
261-SEK1, anti-phospho-Ser-80-SEK1, anti-phospho-Ser-83-ASK1, an-
ti-phospho-Thr-308-Akt, anti-phospho-Ser-473-Akt, anti-Akt, anti-Bad,
and anti-phospho-Ser-136-Bad were purchased from Cell Signaling
(Beverly, MA), and anti-ACTIVE (phospho-Thr-183 and phospho-Tyr-
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185) JNK was purchased from Promega (Madison, WI). Monoclonal
antibodies were purchased from the following companies: anti-JIP3 and
anti-JIP1 from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), anti-
actin from ICN (Costa Mesa, CA), anti-HA (clone 3F10) from Roche
Applied Science, anti-FLAG (clone M2; mouse) from Sigma, and anti-
His (penta-His; mouse) from Qiagen (Valencia, CA). Other chemicals
were purchased from Sigma.
Shuttle Vector Construction—pcDNA3-HA-ASK1 was kindly pro-
vided by Dr. Ichijo (Tokyo Medical and Dental University, Tokyo,
Japan). pAdlox-HA-ASK1 was made by inserting the SpeI/XbaI frag-
ment from pcDNA3-HA-ASK1 into XbaI-cut pAdlox. pcDNA3-
Myc-ASK1 was made by inserting the PCR product of ASK1 to
pcDNA3-Myc. Sense primer was 5-ATTATACGTATAGCACGGAG-
GCGGACGAGGG-3, introducing an SnaBI site, and antisense primer
was 5-CGCGTCTAG ATCAAGTCTGTTTGTTTCGAAAGTCAATG-3,
introducing an XbaI site for inserting into pcDNA3-Myc (BamHI 3
Klenow 3 XbaI). pAdlox-Myc-ASK1 was made by inserting the SpeI/
XbaI fragment from pcDNA3-Myc-ASK1 into SpeI/XbaI-cut pAdlox.
pcDNA3.1-His C-SEK1 was made by inserting a BamHI fragment from
pEBG-SEK1. Adlox-His-SEK1 was made by inserting an SpeI/XbaI
fragment from pcDNA3.1-His C-SEK1 into SpeI/XbaI-cut pAdlox
shuttle vector. pFLAG-CMV5 MKK71, -1, and -2 was kindly pro-
vided by Dr. Hiroshi Nishina (University of Tokyo). After digestion with
EcoRI/SmaI, their fragments were inserted into the EcoRI/EcoRV site of
pcDNA3.1His C. pAdlox-His-MKK71, -1, and -2 were made by in-
serting the HindIII/XbaI-digested His-MKK71, -1, and -2 fragments
into pAdlox. pLNCX-3X HA-p46 JNK1  and pLNCX-HA p54 JNK2 
were kindly provided by Lynn E. Heasley (University of Colorado
Health Sciences Center, Denver, CO). pLNCX-3X HA-p46 JNK1  and
pLNCX-HA p54 JNK2  were digested with HindIII/ClaI, and their
fragments were subcloned into HindIII/AccI-digested pAdlox. pAdlox-
His-JNK1 was also made by inserting an SpeI/XbaI fragment from
pcDNA3.1-His A-JNK1 into SpeI/XbaI-cut pAdlox. pCMV5-FLAG-JIP1
was kindly provided by Dr. R. Davis (University of Massachusetts
Medical School, Worcester, MA). pFLAG-CMV2-JIP1, which was
FLAG-tagged at its N-terminal and restriction enzyme recognition sites
at the flanking sides (5, HindIII; 3, XbaI) was produced by PCR using
the pCMV5-FLAG-JIP1 as template. Sense primer was 5- TAATA-
AGCTTGCGGAGCGAGAGAGCGGCCTG-3, and antisense primer
was 5-GCCGTCTAGACTACTCCAAGTAGATATCTTC-3. pAdlox-
FLAG-JIP1 was produced by inserting the SpeI/XbaI fragment from
FLAG-CMV2JIP1 into SpeI/XbaI-cut pAdlox shuttle vector.
pcDNA3-FLAG-JIP3 was kindly provided by Dr. Yoshioka (Kanazawa
University, Japan). pAdlox-FLAG-JIP3, which was FLAG-tagged at its
N-terminal and restriction enzyme recognition sites at the flanking
sides (5, SphI; 3, AccI) was produced by PCR using the
pcDNA3-FLAG-JIP3 as template. Sense primer was 5-CTGCGCAT-
GCTGATGGACTACAAAGACGATGACGACAAGCT-3, and antisense
primer was 5-CATCTAGTCGACTCACTCAGGGGTGTAGGACAC-
CTGCC-3. Adlox-HA-Akt1 (wild type Akt1 or kinase-inactive Akt1
(K179M)) was produced by inserting an HindIII/EcoRI fragment from
pCMV6-HA-Akt1 into HindIII/EcoRI-cut pAdlox shuttle vector.
Adenoviral Vector Construction—All recombinant adenoviruses were
constructed by employing the Cre-lox recombination system (16). The
selective cell line CRE8 has an -actin-based expression cassette driv-
ing a Cre recombinase gene with an N-terminal nuclear localization
signal stably integrated into 293 cells. Transfections were done by using
Lipofectamine reagent (Invitrogen). 5 105 cells were split into a 6-well
plate 1 day before transfection. For the production of recombinant
adenovirus, 2 g of SfiI-digested Adlox/FLAG-JIP1, Adlox/FLAG-JIP3,
Adlox/His-SEK1, Adlox/His-MKK71, Adlox/His-MKK71, Adlox/His-
MKK72, Adlox/HA-JNK1, Adlox/HA-JNK2, or Adlox/HA-Akt1, 5 vi-
ral genomic DNA (2 g) were co-transfected into CRE8 cells. The
recombinant adenoviruses were generated by intermolecular homolo-
gous recombination between the shuttle vector and 5 viral DNA. The
new virus had an intact packaging site and carried a recombinant gene.
Plaques were harvested, analyzed, and purified. The insertion of vari-
ous types of shuttle vector to adenovirus was confirmed by Western blot
analysis, after infection of corresponding recombinant adenovirus into
DU-145 cells.
Site-directed Mutagenesis—The QuikChange site-directed muta-
genesis kit (Stratagene, La Jolla, CA) was used to make point mutat-
ions in SEK1 protein. Threonine residue in mouse SEK1 was replaced
with alanine (T259A). Sense primer oligonucleotide (5-GACTCTATT-
GCCAAGGCAAGAGATGCTGGGTGT-3) and antisense primer oligon-
ucleotide (5-ACACCCAGCATCTCTTGCCTTGGCAATAGAGTC-3)
were used for site-directed mutagenesis. PCR was prepared by adding
5 l of 10 reaction buffer, 20 ng of double-stranded DNA template
(pAdlox-His-SEK1), 125 ng of each sense primer, 125 ng of each anti-
sense primer, 1 l of dNTP mix, double-distilled water to a final volume
of 50 l, and 1 l of Pfu Turbo DNA polymerase (2.5 units/l). PCR was
performed with 14 cycles (95 °C for 30 s, 58 °C for 1 min, 68 °C for 7
min) with initial incubation at 95 °C for 30 s. Following temperature
cycling, the reaction was placed on ice for 2 min to cool the reaction.
After PCR, 1 l of DpnI restriction enzyme (10 units/l) was added
directly to each amplification reaction and incubated at 37 °C for 1 h to
digest the parental supercoiled double-stranded DNA. The DpnI-
treated double-stranded DNA was transformed into Epicurian Coli
XL1-Blue supercompetent cells. Colonies were selected, and each plas-
mid (pAdlox-HA-JNK2) was sequenced using primer (5-GGATGCTA-
ACTTATGTCAGG-3) to confirm mutation.
RNA Interference by siRNA of SEK1, JIP1, or JIP3—To stably ex-
press siRNA for the long term knockdown, pSilencer 2.1-U6 hygro
vector (Ambion, Inc., Austin, TX) was used for clonal cell lines. The
inserts for hairpin siRNA into pSilencer were prepared by annealing
two oligonucleotides. For human SEK1 siRNA, the top strand sequence
was 5-GATCCACGCAAAGCACTGAAGTTGTTCAAGAGACAACTTC-
AGTGCTTTGCGTTTTTTTGGAAA-3, and the bottom strand sequence
was 5-AGCTTTTCCAAAAAAACGCAAAGCACTGAAGTTGTCTCTT-
GAACAACTTCAGTGCTTTGCGTG-3. For human JIP1 siRNA, the top
strand sequence was 5-GATCCGACCTCTCGGAGATCACTGTT-
CAAGAGACAGTGATCTCCGAGAGGTCTTTTTTGGAAA-3, and the
bottom strand sequence was 5-AGCTTTTCCAAAAAAGACCTCTCGG-
AGATCACTGTCTCTTGAACAGTGATCTCCGAGAGGTCG-3. The
annealed insert was cloned into pSilencer 2.1-U6 hygro digested with
BamHI and HindIII. The correct structure of pSilencer 2.1-U6 hygro-
SEK1 or pSilencer 2.1-U6 hygro-JIP1 was confirmed by nucleotide se-
quencing. The resultant plasmid, pSilencer-SEK1 or pSilencer-JIP1,
was transfected into DU-145 cells, and hygromycin B (250 g/ml)-
resistant cell clones were isolated. The interference of SEK1 or JIP1
protein expression was confirmed by immunoblot using anti-SEK1 or
anti-JIP1 antibody.
To down-regulate the JIP3, JIP3 siRNA (Santa Cruz Biotechnology)
was used. Cells were transfected with JIP3 siRNA and incubated for
36 h. The interference of JIP3 protein expression was confirmed by
immunoblot using anti-JIP3 antibody (Upstate, Charlottesville, VA).
Interaction between Proteins—To examine the interaction between
ASK1 and JIP3/JIP1, adenoviruses expressing HA-tagged ASK1
(Ad.HA-ASK1) and FLAG-tagged JIP3/JIP1 (Ad.FLAG-JIP3 or JIP1) at
an MOI of 10 were infected into DU-145 cells in 10-cm culture plates,
respectively. For immunoprecipitation, after 48 h of infection, cells were
lysed in buffer containing 150 mM NaCl, 20 mM Tris-HCl (pH 7.5), 10
mM EDTA, 1% Triton X-100, 1% deoxycholate, 1 mM phenylmethylsul-
fonyl fluoride (PMSF), 80 M aprotinin, 2 mM leupeptin, and the lysates
were incubated with 1 g of anti-HA (clone 3F10; Roche Applied Sci-
ence) or 3 g of anti-FLAG M2 mouse IgG1 (Sigma) for 2 h. After the
addition of protein G-agarose (Santa Cruz Biotechnology), the lysates
were incubated for an additional 2 h. The beads were washed three
times with the lysis buffer, separated by SDS-PAGE, and immuno-
blotted with mouse anti-FLAG or mouse anti-HA (clone 12CA5; Roche
Applied Science). Proteins in the membranes were then visualized
using the enhanced chemiluminescence (ECL) reagent as recommended
by the manufacturer (Amersham Biosciences).
To examine the interaction between SEK1/MKK71/JNK1 and JIP1/
JIP3, anti-His antibody was used for immunoprecipitation. To examine
the interaction between JNK2 and JIP1/JIP3, anti-HA antibody was
used for immunoprecipitation.
Immune Complex Kinase Assay—For in vitro kinase assay of Akt1,
DU-145 cells were lysed in a buffer solution containing 20 mM Tris-HCl
(pH 7.5), 150 mM NaCl, 5 mM EGTA, 10 mM NaF, 1% Triton X-100, 0.5%
deoxycholate, 2 mM DTT, 1 mM sodium orthovanadate, 1 mM PMSF, and
FIG. 1. Activation of JNK during glucose deprivation. DU-145
cells were exposed to glucose-free medium for various times (10–360
min). After incubation, cells were harvested, and Western blot analysis
(WB) was performed with anti-ACTIVE JNK, anti-JNK2, or anti-actin
antibody as the loading control.
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protein inhibitor mixture solution (Sigma). Cell extracts were clarified
by centrifugation, and the supernatants were immunoprecipitated with
mouse Akt antibody (Cell Signaling) and protein G-agarose (Santa Cruz
Biotechnology). The beads were washed twice with a solution contain-
ing 150 mM NaCl, 20 mM Tris-HCl (pH 7.5), 5 mM EGTA, 2 mM DTT, 1
mM sodium orthovanadate, 1 mM PMSF, and protein inhibitor mixture
solution and washed once with the kinase buffer solution, and then they
were subjected to kinase assays. To examine the Akt1 catalytic activity,
GST-tagged fusion Bad protein (Santa Cruz Biotechnology) was used as
a substrate of Akt1. 1 g of Bad was incubated with immunoprecipi-
tated Akt1 in kinase buffer containing 20 mM Tris-HCl (pH 7.5), 20 mM
MgCl2, 1 mM sodium orthovanadate, 2 mM DTT, and 20 M ATP at 30 °C
for 1 h. Finally, the reaction was stopped by adding 2 Laemmli buffer.
Phosphorylated proteins were resolved by SDS-PAGE and analyzed by
immunoblotting using anti-phospho-Bad (Ser-136) antibody (Cell Sig-
naling Technology, Inc., Beverly, MA). For in vitro kinase assay of
SEK1/ASK1 phosphorylation by Akt1, DU-145 cells were co-infected
with Ad.His-SEK1/Ad.Myc-ASK1 and Ad.HA-Akt1 at an MOI of 10.
After 48 h of infection, cells were incubated in glucose-free medium for
1 h and then lysed in a buffer solution containing 20 mM Tris-HCl (pH
7.5), 150 mM NaCl, 5 mM EGTA, 10 mM NaF, 1% Triton X-100, 0.5%
deoxycholate, 2 mM DTT, 1 mM sodium orthovanadate, 1 mM PMSF, and
protein inhibitor mixture solution (Sigma). Cell extracts were clarified
by centrifugation, and the supernatants were immunoprecipitated with
anti-His/anti-Myc antibody and protein G-agarose. The beads were
washed three times with a solution containing 150 mM NaCl, 20 mM
Tris-HCl (pH 7.5), 5 mM EGTA, 2 mMDTT, 1 mM sodium orthovanadate,
1 mM PMSF and protein inhibitor mixture solution and washed once
with the kinase buffer solution, and then they were subjected to kinase
assays. 0.5 g of GST-JNK/GST-SEK1 was incubated with immunopre-
cipitated His-SEK1/Myc-ASK1 in kinase buffer containing 20 mM Tris-
HCl (pH 7.5), 20 mM MgCl2, 1 mM sodium orthovanadate, 2 mM DTT,
FIG. 2. Interaction between JIP3
and various types of the ASK1-MEK-
JNK signaling proteins during glu-
cose deprivation. DU-145 cells were
co-infected with adenoviral vector
containing FLAG-tagged JIP3 and HA-
ASK1, His-MKK71, His-MKK71, His-
MKK72, His-SEK1, HA-JNK1, or HA-
JNK2 at an MOI of 10. After 48 h of
infection, cells were exposed to glucose-
free medium for various times (10–120
min). Cell lysates were immunoprecipi-
tated (IP) with anti-FLAG antibody (A),
anti-His antibody (B–F), or anti-HA anti-
body (G) and immunoblotted (WB) with
anti-FLAG, anti-His, or anti-HA antibody
(upper panels). The presence of HA-ASK1
or FLAG-JIP3 in the lysates was verified
by immunoblotting (lower panels).
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and 20 M ATP at 30 °C for 1 h. Finally, the reaction was stopped by
adding 2 Laemmli buffer. Phosphorylated proteins were resolved by
SDS-PAGE and analyzed by immunoblotting using anti-ACTIVE JNK
antibody (Promega, Madison, WI) or anti-phospho-SEK1 (Thr-261) an-
tibody (Cell Signaling Technology). For the in vitro kinase assay of JIP1
phosphorylation by JNK2, DU-145 cells were infected with various
types of Ad.HA-JNK2 (wild type, T183A, and Y185F) at an MOI of 10.
After 48 h of infection, cells were incubated in glucose-free medium for
1 h and then lysed in a buffer solution containing 20 mM Tris-HCl (pH
7.5), 150 mM NaCl, 5 mM EGTA, 10 mM NaF, 1% Triton X-100, 0.5%
deoxycholate, 2 mM DTT, 1 mM sodium orthovanadate, 1 mM PMSF, and
protein inhibitor mixture solution (Sigma). Cell extracts were clarified
by centrifugation, and the supernatants were immunoprecipitated with
rat anti-HA antibody and protein G-agarose. The beads were washed
three times with a solution containing 150 mM NaCl, 20 mM Tris-HCl
(pH 7.5), 5 mM EGTA, 2 mM DTT, 1 mM sodium orthovanadate, 1 mM
PMSF, and protein inhibitor mixture solution and washed once with the
kinase buffer solution, and then they were subjected to kinase assays.
0.5 g of GST-JIP1 or GST-JIP1 (T103A) was incubated with immuno-
precipitated HA-JNK2 (WT, T183A, 185F) in kinase buffer containing
20 mM Tris-HCl (pH 7.5), 20 mM MgCl2, 1 mM sodium orthovanadate,
2 mM DTT, 20 M ATP, and 100 Ci/ml [-32P]ATP at 30 °C for 1 h.
Finally, the reaction was stopped by adding 2 Laemmli buffer. Phos-
phorylated proteins were resolved by SDS-PAGE and analyzed by
autoradiography.
Immunoblot Analysis—Cell lysates were subjected to electrophoresis
on 10% polyacrylamide gels containing SDS under reducing conditions,
and the proteins in the gels were transferred onto a polyvinylidine
difluoride membrane. The membranes were incubated with 7% (w/v)
skim milk in PBST (PBS containing 0.1% (v/v) Tween 20) and then
reacted with primary antibodies. After washing three times with PBST,
the membranes were incubated with horseradish peroxidase-conju-
gated anti-IgG. Then the proteins were detected with the ECL reagent.
RESULTS
JNK Activation during Glucose Deprivation—We previously
reported that glucose deprivation activates JNK. To examine
the time course of JNK activation during glucose deprivation,
DU-145 cells were exposed to glucose-free medium for various
times (10–120 min). Fig. 1 shows that three isoforms of JNK
(p43, p46, and p54) were phosphorylated during glucose depri-
vation. Phosphorylation of JNK occurred within 10–30 min,
gradually increased until 60 min, and then decreased during
glucose deprivation. We postulated that bistable systems in the
cells are involved in the regulation of JNK activation during
glucose deprivation. Bistability can result from cross-talking
between scaffolding proteins. This possibility was further
examined.
Interaction between JIP3/JIP1 and ASK1-MEK-JNK Signal-
ing Proteins during Glucose Deprivation—Previous studies
have shown that JIP3 interacts with ASK1 (8). In this study,
we investigated whether glucose deprivation promotes the in-
teraction between JIP3 and ASK1. Fig. 2A shows that ASK1
associated with JIP3 in the presence of glucose. The interaction
between these proteins gradually increased during glucose dep-
rivation and reached a maximum at 1 h of glucose deprivation.
This and the following experiments are compared diagrammat-
ically in Table I. We further examined the interaction between
JIP3 and downstream molecules (SEK1, MKK71, MKK71,
MKK72, JNK1, and JNK2) of ASK1 signaling (Fig. 2, B–G).
Interestingly, the kinetics of interaction between them during
glucose deprivation were not identical. SEK1, MKK71, and
JNK1 rapidly interacted with JIP3, reached a maximum at up
to 30 min, and then dissociated from JIP3 during prolonged
glucose deprivation (Fig. 2, B, C, and F). In contrast, little or no
change in the interaction between JIP3 and MKK71/JNK2
was observed in the presence or absence of glucose (Fig. 2, D
and G). On the contrary, interaction between MKK72 and
JIP3 during glucose deprivation increased and reached a max-
imum within 10 min and then the interaction was sustained.
We further investigated the interaction between the ASK1-
MEK-JNK signaling proteins and JIP1, another scaffolding
protein (Fig. 3). Interaction between JIP1 and ASK1/MKK71
during glucose deprivation increased and reached a maximum
at 60 min and then the interaction was sustained. Interaction
between MKK72 and JIP1 during glucose deprivation rapidly
increased and reached a maximum at 60 min and then the
interaction was sustained. Interaction between JIP1 and
MKK71/JNK2 increased, reached a maximum within 30–60
min, and then decreased during glucose deprivation (Fig. 3, D
andG). On the contrary, interaction between JIP1 and SEK1 or
JNK1 was not detectable or not changed, respectively (Figs. 3,
B and F). We summarized our observations in Table I. In this
table, we have noticed that SEK1 and JNK2 were distinctively
different from other proteins in terms of interacting with scaf-
folding proteins during glucose deprivation. Thus, we postu-
lated that these proteins act as mediators for cross-talking
between scaffolding proteins.
Role of JIP3 in the Activation of SEK1 and JNK during
Glucose Deprivation—Data from Fig. 2 show the interaction
between JIP3 and downstream molecules of ASK1 signaling.
We hypothesized that this interaction is essential for activating
downstream molecules of ASK1 signaling during glucose dep-
rivation. To test this hypothesis, DU-145 cells were transfected
with JIP3 siRNA or mock siRNA. Fig. 4 shows that the expres-
sion of JIP3 was effectively inhibited by siJIP3. Glucose depri-
vation-induced SEK1 and JNK activation were also inhibited
in siJIP3-transfected cells. These results reveal that JIP3 plays
an important role in activation of SEK1 and JNK.
Role of ASK1 in the Interaction between JIP3 and SEK1
during Glucose Deprivation—Previous studies have shown that
ASK1 phosphorylates JIP3 and its phosphorylation facilitates
interactions of JIP3 with SEK1 (8). To examine whether ASK1
has an effect on the interaction between JIP3 and SEK1 during
glucose deprivation, cells were infected with adenoviral vector
TABLE I
Summary of data from experiments shown in Figs. 2 and 3
The relative ratio of the intensity of each kinase is plotted as a function of various periods of incubation in glucose-free medium. The data are
a compilation of two or three separate experiments.
ASK1 SEK1 MKK71 MKK71 MKK72 JNK1 JNK2
JIP3
0 min       
10 min       
30 min       
60 min       
120 min       
JIP1
0 min       
10 min       
30 min       
60 min       
120 min       
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containing wild-type ASK1 (Fig. 5A) or mutant-type (kinase-
inactive form) ASK1 (Fig. 5B) prior to glucose deprivation.
Fig. 5 shows that glucose deprivation enhanced SEK1-JIP3
binding regardless of overexpressing either type of ASK1.
SEK1 dissociated from JIP3 after 60 min of glucose depriva-
tion in wild-type ASK1-overexpressed cells (Fig. 5A, lane 5).
However, unlike overexpression of wild-type ASK1, overex-
pression of mutant type ASK1 prevented dissociation of
SEK1 from JIP3 during prolonged glucose deprivation. We
also observed that overexpression of wild-type ASK1 pro-
moted JNK and SEK1 activation and sustained their activa-
tion during glucose deprivation (Fig. 5A). However, overex-
pression of mutant-type ASK1 suppressed JNK activation,
and no detectable SEK1 phosphorylation on the Thr-261
residue was observed during glucose deprivation (Fig. 5B).
We previously reported that glucose deprivation activates the
ASK1-SEK1-JNK signal transduction pathway. Taken to-
gether, our results suggest that ASK1 kinase activity is not
important for glucose deprivation-induced SEK1-JIP3 bind-
ing. Dissociation of activated (phosphorylated) SEK1 from
JIP3 during prolonged glucose deprivation indicates that
ASK1 kinase activity plays an important role in dissociation
of SEK1 from JIP3.
Role of SEK1 in JNK Activation during Glucose Depriva-
tion—To examine whether phosphorylation of SEK1 is essen-
tial for dissociation from JIP3, we employed site-directed
FIG. 3. Interaction between JIP1
and various types of the ASK1-MEK-
JNK signaling proteins during glu-
cose deprivation. DU-145 cells were co-
infected with adenoviral vector containing
FLAG-tagged JIP1 and HA-ASK1, His-
MKK71, His-MKK71, His-MKK72,
His-SEK1, HA-JNK1, or HA-JNK2 at an
MOI of 10. After 48 h of infection, cells
were exposed to glucose-free medium for
various times (10–120 min). Cell lysates
were immunoprecipitated (IP) with anti-
FLAG antibody (A), anti-His antibody
(B–F), or anti-HA antibody (G) and immu-
noblotted (WB) with anti-FLAG, anti-His,
or anti-HA antibody (upper panels). The
presence of HA-ASK1 or FLAG-JIP1 in the
lysates was verified by immunoblotting
(lower panels).
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mutagenesis to create a point mutation at residue Thr-259
(Thr 3 Ala) of mouse SEK1. Fig. 6 shows that wild-type
SEK1 associated with JIP3 within 30 min of glucose depri-
vation and dissociated from JIP3 after 120 min of glucose
deprivation. Unlike wild-type SEK1, mutant-type SEK1 did
not dissociate from JIP3 during prolonged glucose depriva-
tion. Interestingly, overexpression of mutant-type SEK1 sup-
pressed glucose deprivation-induced JNK phosphorylation
(Fig. 6). These results suggest that SEK1 has an effect on
JNK activation.
Role of SEK1 in the Interaction between JNK2 and JIP1
during Glucose Deprivation—As shown in Figs. 2 and 3 and
Table I, during prolonged glucose deprivation, SEK1 dissoci-
ates from JIP3, and JNK2 associates with JIP1. We postulated
that activated SEK1, which dissociates from JIP3, regulates
the interaction between JNK2 and JIP1. To test this hypothe-
sis, we attempted to silence SEK1 expression by using siRNA
of SEK1. DU-145 cells were stably transfected with either
pSilencer control plasmid or pSilencer-siSEK1 vector. We
selected several stable transfectants and chose one transfec-
tant for further studies. Fig. 7 shows that the expression of
SEK1 was effectively reduced in the siSEK#4 transfectant. To
examine the role of SEK1 in the interaction between JIP1 and
JNK2, pSilencer or siSEK1#4 transfectant was co-infected with
Ad.FLAG-JIP1 and Ad.HA-JNK2. Fig. 7 shows that JNK2
bound to JIP1 in pSilencer transfectant but not in siSEK1#4
transfectant during glucose deprivation. Previous studies have
shown that Thr-183 and Tyr-185 residues of JNK2 need to be
phosphorylated for its activation (16). We postulated that phos-
phorylation of both residues is essential for JNK2-JIP1 inter-
action during glucose deprivation. To test this hypothesis,
Thr-183 and Tyr-185 of JNK2 were replaced with alanine
(T183A) and phenylalanine (Y185F), respectively. Fig. 8A
shows that glucose deprivation increased the interaction be-
tween JIP1 and wild-type JNK2 or T183A mutant-type JNK2
but not Y185F mutant-type JNK2. These data suggest that
phosphorylation of Tyr-185 residue but not that of Thr-183 is
required for binding of JNK2 to JIP1 during glucose depriva-
tion. Previous studies have demonstrated that activated JNK is
involved in phosphorylation of JIP1 on the Thr-103 residue. To
test this possibility, we employed site-directed mutagenesis to
create a point mutation at residue Thr-103 (Thr3 Ala) of JIP1.
Fig. 8B shows that JIP1 was phosphorylated by only wild-type
JNK2 but not by either T183A or Y185F mutant-type JNK2
during glucose deprivation. Data from immune complex kinase
assays show that glucose deprivation-induced phosphorylation
of JIP1 by JNK2 was reduced in T103A mutant-type JIP1 (Fig.
8C). These results suggest that phosphorylation of both
Thr-183 and Tyr-185 residue is necessary for full activation of
JNK2 enzyme to phosphorylate its substrates such as JIP1 on
Thr-103 residue.
Dissociation of Akt1 from JIP1 during Glucose Depriva-
tion—Previous studies have shown that Akt1 associates with
JIP1 (14). We hypothesized that JNK2-induced phosphoryl-
ation of JIP1 leads to dissociation of Akt1 from JIP1 during
glucose deprivation. We also postulated that association of
JIP1 with Akt1 inhibits the enzymatic activity of Akt1 and
dissociation of Akt1 from JIP1 restores Akt1 enzyme activity.
To test the hypothesis, interaction between Akt1 and wild-
type JIP1 was examined during glucose deprivation. Fig. 9A
shows that JIP1 associated with Akt1 in the presence of
glucose. Prolonged glucose deprivation dissociated Akt1 from
wild-type JIP1 (Fig. 9A) but not mutant-type JIP1 (T103A)
(Fig. 9B). Fig. 9C shows that endogenous Akt1 catalytic ac-
tivity, which was measured by using an Akt-specific sub-
strate, Bad, was increased during prolonged (2–4-h) glucose
FIG. 4. Role of JIP3 in the activation of SEK1 and JNK during
glucose deprivation. DU-145 cells were transfected with JIP3 siRNA
or mock siRNA. After 36 h of incubation, cells were exposed to glucose-
free medium for 60 min. Cell lysates were immunoblotted (WB) with
anti-JIP3, anti-ACTIVE JNK, anti-JNK2, anti-phospho-SEK1, anti-
SEK1, or anti-actin antibody. Actin was used to confirm that similar
amounts of proteins were loaded in each lane.
FIG. 5.Role of ASK1 in the interaction between JIP3 and SEK1
during glucose deprivation. DU-145 cells were co-infected with
adenoviral vector containing His-tagged SEK1 (Ad.His-SEK1), FLAG-
tagged JIP3 (Ad.FLAG-JIP3), and HA-tagged ASK1 wild type (Ad.HA-
ASK1WT) (A) or HA-tagged ASK1 kinase-inactive form K709M (Ad.HA-
ASK1KM) (B) at an MOI of 10. After 48 h of infection, cells were
exposed to glucose-free medium for various times (10–120 min). Cell
lysates were immunoprecipitated (IP) with anti-His antibody and im-
munoblotted (WB) with anti-FLAG or anti-His antibody (upper panels).
The presence of FLAG-JIP3, HA-Akt1, phospho-JNK, JNK2, phospho-
SEK1, or actin in the lysates was verified by immunoblotting (lower
panels). Actin was used to confirm that similar amounts of proteins
were loaded in each lane.
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deprivation. The inhibitory role of JIP1 for Akt1 was further
investigated by knockdown of JIP1 expression. DU-145 cells
were stably transfected with either pSilencer control plasmid
or pSilencer-siJIP1. Unlike pSilencer control plasmid-
transfected cells, pSilencer-siJIP1 stably transfected
siJIP1#3 cells contain a low level of JIP1 (Fig. 10A). Glucose
deprivation-induced JNK activation was inhibited in
siJIP1#3 cells (Fig. 10B). Akt1 activity as measured by the
Akt-specific substrate, Bad, in siJIP1#3 cells was higher than
that in pSilencer control plasmid-transfected cells. There was
little or no change in the Akt1 activity in the presence or
absence of glucose in siJIP1#3 cells (Fig. 10C).
Inhibition of SEK1/ASK1 by Akt1 during Glucose Depriva-
tion—We further examined the role of Akt1 in the ASK1-
SEK1-JNK signal transduction during glucose deprivation.
We postulated that prolonged glucose deprivation-induced
dissociation of Akt1 results in the suppression of the ASK1-
SEK1-JNK signal transduction by inhibiting SEK1 and/or
ASK1 activity. Figs. 11, A and C, shows that Akt1 associated
with SEK1 and ASK1, respectively, during prolonged glucose
deprivation (2 h but not 1 h). Fig. 11, B and D, shows that
wild-type Akt1 phosphorylated SEK1 on Ser-80 residue and
ASK1 on Ser-83 residue, respectively, during prolonged glu-
cose deprivation. Loss of SEK1 and ASK1 activity was also
observed during prolonged glucose deprivation as observed
by the disappearance of active JNK (Fig. 11, E and F, lane 4).
Overexpression of dominant negative Akt1 did not promote
ASK1 phosphorylation (Fig. 11D) and inhibited the loss of
FIG. 6. Interaction between JIP3 and wild-type SEK1 or mu-
tant-type SEK1 (T259A) and JNK activation in wild-type SEK1
(pHis-SEK1-WT) plasmid or mutant-type SEK1 (pHis-SEK1-
T259A) transfected DU-145 cells during glucose deprivation.
Cells were infected with Ad.FLAG-JIP3 at an MOI of 10 and transiently
transfected with pHis-SEK1-WT (wild type) or pHis-SEK1-T259A (mu-
tant type). After 48 h of incubation, cells were exposed to glucose-free
medium for various times (30–120 min). Cell lysates were immunopre-
cipitated with anti-His antibody and immunoblotted (WB) with anti-
FLAG or anti-His antibody (upper panels). The presence of phospho-
JNK, JNK2, FLAG-JIP3, or His-SEK1 in the lysates was verified by
immunoblotting (lower panels).
FIG. 7. Role of SEK1 in interaction between JIP1 and JNK2
during glucose deprivation. Control plasmid or pSilencer-siSEK1
stably transfected siSEK#4 cells were infected with Ad.FLAG-JIP1
and/or Ad.HA-JNK2 at an MOI of 10. After 48 h of infection, cells were
exposed to glucose-free medium for 60 min. Cell lysates were immuno-
precipitated with anti-HA antibody and immunoblotted (WB) with anti-
FLAG or anti-HA antibody (upper panels). FLAG-JIP1 in the lysates
was verified by immunoblotting with anti-FLAG, anti-SEK1, or anti-
actin antibody (lower panels).
FIG. 8.Role of Thr-183 and Tyr-185 residues of JNK2 in glucose
deprivation-induced interaction between JNK2 and JIP1 (A)
and JIP1 phosphorylation (B and C). DU-145 cells were infected
with Ad.HA-JNK2-wt, Ad.HA-JNK2-T183A, or Ad.HA-JNK2-Y185F at
an MOI of 10. After 48 h of infection, cells were exposed to glucose-free
medium for 1 h and lysed. A, cell lysates were immunoprecipitated with
anti-HA antibody. Lysates were immunoprecipitated (IP) with anti-HA
antibody and immunoblotted (WB) with anti-FLAG or anti-HA antibody
(upper panels). The presence of FLAG-JIP1 in the lysates was verified
by immunoblotting with anti-FLAG antibody (lower panel). B, to exam-
ine which types of JNK2 can phosphorylate JIP1, 0.5 g of GST-JIP1
was incubated with immunoprecipitated HA-JNK2 in kinase buffer
containing 100 Ci/ml [-32P]ATP at 30 °C for 1 h. Phosphorylated
proteins were resolved by SDS-PAGE and analyzed by autoradiography
(upper panel). The presence of HA-JNK2 in the lysates was verified by
immunoblotting with anti-HA antibody (lower panel). C, to investigate
whether JNK2 phosphorylates JIP1 on Thr-103 residue, DU-145 cells
were infected with Ad.HA-JNK2 at an MOI of 10. After 48 h of infection,
cells were exposed to glucose-free medium for 1 h and lysed. Cell lysates
were immunoprecipitated with anti-HA antibody, and then 0.5 g of
GST-JIP1 (wild type) or GST-JIP1-T103A (mutant type) was incubated
with immunoprecipitated HA-JNK2 in kinase buffer containing 100
Ci/ml [-32P]ATP at 30 °C for 1 h. Phosphorylated proteins were
resolved by SDS-PAGE and analyzed by autoradiography (upper panel).
The presence of HA-JNK2 in the lysates was verified by immunoblot-
ting with anti-HA antibody (lower panel).
Role of SEK1 and Akt1 in Cross-talk between JIP3 and JIP1 26851
 at Y
O
N
SEI U
N
IV
ERSITY
 on July 1, 2014
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
SEK1 and ASK1 activity during prolonged glucose depriva-
tion (Fig. 11, E and F, lane 7).
Model for the Role of SEK1-JNK2 and JIP1-Akt1 in ASK1-
MEK-MAPK Signal Transduction during Glucose Depriva-
tion—Fig. 12 shows a schematic diagram of a theoretical model
based on the literature and data presented here. This model
illustrates the sequential events that occur on scaffolding pro-
teins during glucose deprivation: glucose deprivation3 ASK1-
JIP3 binding 3 phosphorylation of SEK1 at Thr-261 3 phos-
phorylation of JNK2 at Tyr-185 3 JNK2-JIP1 binding 3
MKK7 binding to JIP13 phosphorylation JNK2 at Thr-1833
phosphorylation of JIP1 at Thr-1033 dissociation of Akt1 from
JIP1 3 phosphorylation of SEK1 at Ser-80 and ASK1 at
Ser-83.
DISCUSSION
It is well known that biological regulatory systems usually
have switchlike properties. Positive feedback loops and nega-
tive feedback loops may produce bistable systems under condi-
tions of stress, as commonly exist in tumors. Our studies reveal
that SEK1-JNK2 and Akt1 are involved in a cross-talk between
JIP3 and JIP1 to negatively regulate the ASK1-SEK1-JNK
signal transduction during prolonged glucose deprivation.
Previous studies have shown that JNK is activated by dual
phosphorylation on the tripeptide motif Thr-X-Tyr (18). Two
MAPKKs, SEK1 and MKK7, synergistically activate JNK (7, 8,
19, 20). SEK1 prefers the Tyr-185 residue, and MKK7 prefers
the Thr-183 residue (17, 19). Our data demonstrate that full
activation of JNK requires the phosphorylation of both residues
(Fig. 8B). However, phosphorylation of JNK2 on Tyr-185 is
prerequisite for the recruitment of JNK2 to JIP1 (Fig. 8A).
Interestingly, knockdown of SEK1 mRNA and protein by
siRNA for SEK1 leads to inhibition of JIP1-JNK2 binding dur-
FIG. 9. Interaction between Akt1 and JIP1 during glucose dep-
rivation. A and B, DU-145 cells were co-infected with adenoviral vector
containing HA-tagged Akt1 (Ad.HA-Akt1) and FLAG-tagged wild-type
JIP1 (Ad.FLAG-JIP1-WT) or mutant-type JIP1 (Ad.FLAG-JIP1-T103A)
at an MOI of 10. After 48 h of infection, cells were exposed to glucose-
free medium for various times (10–120 min). Cell lysates were immu-
noprecipitated (IP) with anti-HA antibody and immunoblotted (WB)
with anti-FLAG or anti-HA antibody (upper panels). The presence of
FLAG-JIP1 in the lysates was verified by immunoblotting (lower panel).
C, DU-145 cells were exposed to glucose-free medium for various times
(1–4 h). Lysates were immunoprecipitated with anti-Akt (mouse mono-
clonal antibody) antibody. Immunoprecipitates were analyzed for en-
dogenous Akt1 catalytic activity in vitro using GST-Bad (Santa Cruz
Biotechnology) protein as substrate. GST-Bad or phosphorylated GST-
Bad was detected with anti-Bad or anti-phospho-Ser-136-Bad antibody,
respectively. The presence of Akt1 was verified by immunoblotting with
anti-Akt1 antibody.
FIG. 10. Glucose deprivation-induced JNK activation in con-
trol plasmid (pSilencer) or pSilencer-siJIP1 stably transfected
DU-145 cells. A, immunoblot of JIP1 expression in control vector
transfected (pSilencer) or pSilencer-siJIP1 stably transfected (siJIP1#1,
-2, -3, and -4) single cell clones from DU-145 cells. Lysates containing
equal amounts of protein (20 g) were separated by SDS-PAGE and
immunoblotted with anti-JIP1 antibody. B, control plasmid or pSi-
lencer-siJIP1 stably transfected siJIP1#3 cells were exposed to glucose-
free medium for 1 or 2 h. After incubation, cells were harvested, and
Western blot analysis (WB) was performed with anti-ACTIVE JNK or
anti-actin antibody as the loading control. C, control plasmid or pSi-
lencer-siJIP1 stably transfected siJIP#3 cells were exposed to glucose-
free medium for 1 or 2 h. After incubation, cells were harvested, and
lysates were immunoprecipitated (IP) with anti-Akt (mouse monoclonal
antibody) antibody. Immunoprecipitates were analyzed for Akt1 cata-
lytic activity in vitro using GST-Bad (Santa Cruz Biotechnology) pro-
tein as substrate. GST-Bad or phosphorylated GST-Bad was detected
with anti-Bad or anti-phospho-Ser-136-Bad antibody, respectively. The
presence of Akt1 was verified by immunoblotting with anti-Akt1
antibody.
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ing glucose deprivation (Fig. 7). Taken together, these results
suggest that SEK1-mediated JNK2 phosphorylation is neces-
sary for the JIP1-JNK2 binding. Our observations were con-
sistent with previous reports. It is well known that the JIP
family of scaffold proteins associate with MAPK kinase kinase,
MAPK kinase, and MAPK and create a functional signaling
module to control the specificity of signal transduction (5). JIP1
scaffold facilitates JNK activation in a mixed lineage protein
kinase-MKK7-dependent manner (9, 22–24). JIP-3 mediates
signaling to JNK by interacting with ASK1, MEKK1, and
MKK4 (7, 8). Indeed, our data show that glucose deprivation
activates the JIP3-scaffolded ASK1-SEK1 signaling pathway
and subsequently phosphorylates JNK2 on Tyr-185 but not
Thr-183. Phosphorylated JNK2 on Tyr-185 binds to JIP1 and
FIG. 11. Interaction between Akt1 and SEK1 (or ASK1) and its role in SEK1/ASK1 enzyme activity during glucose deprivation. A
and C–F, DU-145 cells were co-infected with Ad.HA-Akt1 (wild type or dominant negative mutant type) and Ad.His-SEK1 (or Ad.Myc-ASK1) at
an MOI of 10. After 48 h of incubation, cells were exposed to glucose-free medium for 1 or 2 h and lysed. Cell lysates were immunoprecipitated (IP)
with anti-His (A) or anti-Myc antibody (C) and immunoblotted (WB) with anti-HA, anti-His, or Myc antibody (upper panels). The presence of
HA-Akt1, His-SEK1, or Myc-ASK1 in the lysates were verified by immunoblotting (lower panels). B and D, DU-145 cells were exposed to
glucose-free medium for 1 or 2 h and lysed. Endogenous Akt1 (B) or Myc-ASK1 (D) was immunoprecipitated with anti-Akt1 or anti-Myc antibody,
respectively. Phosphorylation of SEK1 or that of ASK1 by Akt1 was detected with anti-phospho(Ser-80)-SEK1 or anti-phospho(Ser-83)-ASK1
antibody, respectively (upper panels). The presence of Akt1, phospho-SEK1, SEK1, HA-Akt1, or Myc-ASK1 was verified by immunoblotting (lower
panels). E and F, after 48 h of incubation, cells were exposed to glucose-free medium for 1 or 2 h and then lysed. Lysates were immunoprecipitated
with anti-His or anti-Myc antibody. To examine the catalytic activity of SEK1 or ASK1, 0.5 g of GST-JNK1 or GST-SEK1 was incubated with
immunoprecipitated His-SEK1 or Myc-ASK1, respectively, in kinase buffer containing ATP at 30 °C for 1 h. Phosphorylated proteins were resolved
by SDS-PAGE and analyzed by immunoblotting with anti-ACTIVE JNK or anti-phospho-Thr-261-SEK1 antibody. The presence of GST-JNK1,
His-SEK1, GST-SEK1, or Myc-ASK1 in the immunoprecipitate was verified by immunoblotting (upper panels). The presence of HA-Akt1 (wild type,
dominant negative), His-SEK1, or Myc-ASK1 in the lysates was verified by immunoblotting (lower panels).
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then phosphorylation of JNK2 on Thr-183 probably occurs by
the mixed lineage protein kinase-MKK7 signal. Although
JIP3 and JIP1 are structurally distinct from each other,
cross-talk underlies the relationship between the two scaffold
proteins.
It is well known that Ser/Thr-directed protein kinases of the
Akt family (Akt1 to -3) are important mediators of cell survival
in response to growth factors including insulin and insulin-like
growth factor I (25–28). Akt is activated by phosphoinositide-
dependent kinase 1 and 2 through phosphorylation at Thr-308
and Ser-473 residues (29, 30). A number of proapoptotic pro-
teins have been identified as direct Akt substrates, including
Forkhead transcription factors, caspase-9, glycogen synthase
kinase 3, and Bad (31–38). The proapoptotic function of these
molecules is suppressed upon phosphorylation by Akt. Kim et
al. (14) and Fig. 9A have revealed an interaction between Akt1
and JIP1. Data from our studies reveal that JIP1 negatively
regulates Akt by means of protein-protein interactions (Figs. 9
and 10). Our observations somewhat contradicted a recent
report (39) that JIP1 activates Akt1. At the present time, we
can only speculate that this discrepancy is due to differences in
analytical methods (immunblotting assay versus immune com-
plex kinase assay). Immunoblotting with phosphospecific Akt
antibodies may not truly reflect the catalytic activity of Akt.
Data from immunoblot assays illustrate that phosphorylated
(active form) Akt1 binds to JIP1; however, data from immune
complex kinase assays demonstrate that the enzymatic activity
of Akt1 is suppressed by binding with JIP1. The Akt1-JIP1
interaction is decreased concomitantly with an increase in an
association between JIP1 and JNK (14). The present studies
reveal that JNK2-dependent JIP1 phosphorylation on Thr-103
regulates JIP1-Akt1 binding affinity (Figs. 8 and 9). These
results are consistent with previous reports, which demon-
strate that JNK-mediated phosphorylation of JIP1 on Thr-103
is essential for the regulation of dual zipper-bearing kinase
(DLK) association with JIP1 (11). Dissociation of DLK from
JIP1 results in subsequent DLK oligomerization, autophospho-
rylation, and ultimately module activation of DLK (11). How-
ever, unlike DLK, phosphorylated Akt1 (active form) binds to
JIP1, and dissociation of Akt1 from JIP1 results in the resto-
ration of Akt1 enzyme activity (Fig. 9C). Previous studies re-
ported that JNK activity can be antagonized by Akt kinase
activity in numerous cellular systems (12–15). This is probably
due to inhibition of ASK1 and/or SEK1 activity by Akt1. Our
studies and literature have shown that Akt1 interacts with
ASK1 or SEK1 and inhibits ASK1 or SEK1 enzyme activity by
phosphorylating ASK1 on Ser-83 residue (40) (Fig 11D) or
SEK1 on Ser-80 residue (41) (Fig. 11B), respectively. Taken
together, Akt1-mediated inhibition of SEK1 and/or ASK1 may
act as a negative regulatory feedback loop for the ASK1-MEK-
MAPK signal transduction. Moreover, recent studies have
demonstrated that Akt phosphorylates and activates ARK5, a
member of the AMP-activated protein kinase family, during
glucose deprivation (42, 43). Activated ARK5 phosphorylates
ATM, a tumor suppressor, and subsequently leads to the acti-
vation of p53 by phosphorylation (42). The activation of ARK5,
which is triggered by Akt during glucose deprivation, sup-
presses caspase activation and prevents cell death (21, 44). It is
possible that Akt-activated ARK5 is involved in the negative
regulatory feedback loop. This possibility needs to be investi-
gated in the future.
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